AIMS/HYPOTHESIS: Diabetes is associated with an increased risk of atherosclerotic cardiovascular disease, but whether there is a direct and independent role for impaired glucose control in atherogenesis remains uncertain. We investigated whether diabetes with poor glycaemic control would accelerate atherogenesis in a novel pig model of atherosclerosis, the D374Y-PCSK9(+) transgenic minipig. METHODS: Nineteen minipigs were fed a cholesterol-enriched, high-fat diet; ten of these pigs were injected with streptozotocin to generate a model of diabetes. Restricted feeding was implemented to control the pigs' weight gain and cholesterol intake. After 49 weeks of high-fat feeding, the major arteries were harvested for a detailed analysis of the plaque burden and histological plaque type. RESULTS: Stable hyperglycaemia was achieved in the diabetic minipigs, while the plasma total and LDL-cholesterol and creatinine levels were unaffected. Diabetes failed to increase atherosclerosis in any of the vessels examined. The plaque burden in the aorta and right coronary artery was comparable between the groups, and was even reduced in the left anterior descending (LAD) coronary and iliofemoral arteries in the diabetic pigs compared with the controls. The distribution of plaque types and the collagen and macrophage contents were similar between the groups, except for a reduced infiltration of macrophages in the LAD arteries of the diabetic pigs. CONCLUSIONS/ INTERPRETATION: Poorly controlled diabetes with no alterations in plasma cholesterol or creatinine concentrations did not augment the plaque burden or promote the development of more advanced lesions in this large-animal model of human-like atherosclerosis. This is consistent with clinical studies in patients with type 1 diabetes, indicating that hyperglycaemia per se is not an independent promoter of atherosclerotic disease, but that other diabetes-associated risk factors are important.
AIMS/HYPOTHESIS: Diabetes is associated with an increased risk of atherosclerotic cardiovascular disease, but whether there is a direct and independent role for impaired glucose control in atherogenesis remains uncertain. We investigated whether diabetes with poor glycaemic control would accelerate atherogenesis in a novel pig model of atherosclerosis, the D374Y-PCSK9(+) transgenic minipig. METHODS: Nineteen minipigs were fed a cholesterol-enriched, high-fat diet; ten of these pigs were injected with streptozotocin to generate a model of diabetes. Restricted feeding was implemented to control the pigs' weight gain and cholesterol intake. After 49 weeks of high-fat feeding, the major arteries were harvested for a detailed analysis of the plaque burden and histological plaque type. RESULTS: Stable hyperglycaemia was achieved in the diabetic minipigs, while the plasma total and LDL-cholesterol and creatinine levels were unaffected. Diabetes failed to increase atherosclerosis in any of the vessels examined. The plaque burden in the aorta and right coronary artery was comparable between the groups, and was even reduced in the left anterior descending (LAD) coronary and iliofemoral arteries in the diabeticpigs compared with the controls. The distribution of plaque types and the collagen and macrophage contents were similar between the groups, except for a reduced infiltration of macrophages in the LAD arteries of the diabeticpigs. CONCLUSIONS/ INTERPRETATION: Poorly controlled diabetes with no alterations in plasma cholesterol or creatinine concentrations did not augment the plaque burden or promote the development of more advanced lesions in this large-animal model of human-like atherosclerosis. This is consistent with clinical studies in patients with type 1 diabetes, indicating that hyperglycaemia per se is not an independent promoter of atherosclerotic disease, but that other diabetes-associated risk factors are important.
Authors: Conall M O'Seaghdha; Shih-Jen Hwang; Ashish Upadhyay; James B Meigs; Caroline S Fox Journal: Am J Kidney Dis Date: 2010-11 Impact factor: 8.860
Authors: Damir Hamamdzic; Robert S Fenning; Dhavalkumar Patel; Emile R Mohler; Ksenia A Orlova; Alexander C Wright; Raul Llano; Martin G Keane; Richard P Shannon; Morris J Birnbaum; Robert L Wilensky Journal: Am J Physiol Heart Circ Physiol Date: 2010-07-02 Impact factor: 4.733
Authors: Adriana Zuccollo; Chaomei Shi; Roberto Mastroianni; Karlene A Maitland-Toolan; Robert M Weisbrod; Mengwei Zang; Shanqin Xu; Bingbing Jiang; Jennifer M Oliver-Krasinski; Antonio J Cayatte; Stefano Corda; Gilbert Lavielle; Tony J Verbeuren; Richard A Cohen Journal: Circulation Date: 2005-10-31 Impact factor: 29.690
Authors: Song Chai; Qing Chai; Carl C Danielsen; Peter Hjorth; Jene R Nyengaard; Thomas Ledet; Yu Yamaguchi; Lars M Rasmussen; Lise Wogensen Journal: Circ Res Date: 2005-02-10 Impact factor: 17.367
Authors: P Keren; J George; A Shaish; H Levkovitz; Z Janakovic; A Afek; I Goldberg; J Kopolovic; G Keren; D Harats Journal: Diabetes Date: 2000-06 Impact factor: 9.461
Authors: Jon C Olson; John R Erbey; Kimberly Y Z Forrest; Katherine Williams; Dorothy J Becker; Trevor J Orchard Journal: Metabolism Date: 2002-02 Impact factor: 8.694
Authors: Yi-Xin Wang; Rick Fitch; Weiwei Li; Matthias Werner; Meredith Halks-Miller; Bill Lillis; Ronald Vergona; Joe Post; Mark E Sullivan; Peter F Verhallen Journal: Vascul Pharmacol Date: 2002-07 Impact factor: 5.773
Authors: Aimee E Vozenilek; Matthew Vetkoetter; Jonette M Green; Xinggui Shen; James G Traylor; Ronald L Klein; A Wayne Orr; Matthew D Woolard; David M Krzywanski Journal: J Vasc Res Date: 2018-02-16 Impact factor: 1.934
Authors: Hendawy Om; Mehrez E El-Naggar; Mona El-Banna; Moustafa M G Fouda; Sarah I Othman; Ahmed A Allam; Osama M Morsy Journal: Invest New Drugs Date: 2020-02-11 Impact factor: 3.850
Authors: Maximilian Kleinert; Christoffer Clemmensen; Susanna M Hofmann; Mary C Moore; Simone Renner; Stephen C Woods; Peter Huypens; Johannes Beckers; Martin Hrabe de Angelis; Annette Schürmann; Mostafa Bakhti; Martin Klingenspor; Mark Heiman; Alan D Cherrington; Michael Ristow; Heiko Lickert; Eckhard Wolf; Peter J Havel; Timo D Müller; Matthias H Tschöp Journal: Nat Rev Endocrinol Date: 2018-01-19 Impact factor: 43.330
Authors: Claudia Goettsch; Joshua D Hutcheson; Sumihiko Hagita; Maximillian A Rogers; Michael D Creager; Tan Pham; Jung Choi; Andrew K Mlynarchik; Brett Pieper; Mads Kjolby; Masanori Aikawa; Elena Aikawa Journal: Atherosclerosis Date: 2016-06-09 Impact factor: 5.162
Authors: Jill K Badin; Ayeeshik Kole; Benjamin Stivers; Victor Progar; Anisha Pareddy; Mouhamad Alloosh; Michael Sturek Journal: J Transl Med Date: 2018-03-09 Impact factor: 5.531